Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsVIALStandard

NEUPOGEN

FILGRASTIM

Standard Dose
300MCG/1ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview NEUPOGEN is listed in Drugs@FDA under application 103353 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient FILGRASTIM Form and strength VIAL - 300MCG/1ML Sponsor AMGEN Submission history Latest submission status date: 2025-04-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview NEUPOGEN is listed in Drugs@FDA under application 103353 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient FILGRASTIM Form and strength VIAL - 300MCG/1ML Sponsor AMGEN Submission history Latest submission status date: 2025-04-18 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.